CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 26 filers reported holding CARDIOME PHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $21,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,195,692 | $4,953,000 | 2.97% |
| Tamarack Advisers, LP | 1,875,000 | $2,906,000 | 1.59% |
| CLOUGH CAPITAL PARTNERS L P | 2,667,585 | $4,135,000 | 0.34% |
| Rock Springs Capital Management LP | 1,200,000 | $1,860,000 | 0.08% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,678,364 | $7,251,000 | 0.06% |
| KNOTT DAVID M | 67,978 | $105,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 6,184,266 | $9,586,000 | 0.01% |
| AlphaOne Investment Services, LLC | 10,625 | $16,000 | 0.01% |
| A.R.T. Advisors, LLC | 34,872 | $54,000 | 0.00% |
| Virtu Financial LLC | 11,693 | $18,000 | 0.00% |